INS and Insulin resistance: T2DM, characterized by insulin resistance in target tissue, relatively insufficient insulin secretion, and subsequent β-cell dysfunction, is often non-symptomatic; and patients with T2DM seek medical care only for complications such as vision loss, heart attack, or limb gangrenes (28, 32).